Low-Dose Radiation Reduces Doxorubicin-Induced Myocardial Injury Through Mitochondrial Pathways

The use of doxorubicin (DOX) as an anthraquinone antineoplastic agent is limited due to its cardiotoxicity. Our previous study suggested that low-dose radiation (LDR) could mitigate the cardiotoxicity induced by DOX via suppressing oxidative stress and cell apoptosis. However, the molecular targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Di, Jiang, Xin, Meng, Xinxin, Liu, Dandan, Du, Yanwei, Zhao, Lijing, Jiang, Hongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926390/
https://www.ncbi.nlm.nih.gov/pubmed/36798636
http://dx.doi.org/10.1177/15593258231155789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926390/
https://www.ncbi.nlm.nih.gov/pubmed/36798636
http://dx.doi.org/10.1177/15593258231155789

Ejemplares similares